| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,074 |
18,292 |
$1.16M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
24,168 |
21,446 |
$979K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,373 |
4,754 |
$413K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,851 |
4,229 |
$354K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
15,576 |
12,946 |
$278K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,091 |
987 |
$258K |
| 80053 |
Comprehensive metabolic panel |
6,229 |
5,496 |
$137K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,722 |
1,580 |
$128K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,619 |
4,424 |
$112K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,212 |
2,139 |
$104K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,421 |
3,935 |
$97K |
| 71046 |
Radiologic examination, chest; 2 views |
877 |
842 |
$85K |
| 36415 |
Collection of venous blood by venipuncture |
4,324 |
3,852 |
$82K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,796 |
5,929 |
$77K |
| 84703 |
|
1,194 |
1,109 |
$71K |
| 84484 |
|
799 |
555 |
$68K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
920 |
901 |
$59K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
18,653 |
15,076 |
$55K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,924 |
1,012 |
$40K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
138 |
135 |
$40K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
647 |
550 |
$35K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
652 |
632 |
$32K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,452 |
1,330 |
$28K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
653 |
634 |
$27K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
114 |
113 |
$27K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,246 |
2,800 |
$23K |
| 80061 |
Lipid panel |
674 |
671 |
$20K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
566 |
538 |
$20K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
81 |
74 |
$20K |
| 99223 |
Prolong inpt eval add15 m |
343 |
297 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
659 |
566 |
$17K |
| 87081 |
|
673 |
663 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
513 |
512 |
$17K |
| 81003 |
|
1,127 |
1,070 |
$16K |
| 71045 |
Radiologic examination, chest; single view |
356 |
343 |
$16K |
| 99233 |
Prolong inpt eval add15 m |
492 |
303 |
$15K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
180 |
177 |
$12K |
| 87070 |
|
345 |
330 |
$12K |
| 73610 |
|
71 |
64 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
112 |
105 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
193 |
183 |
$9K |
| 81001 |
|
1,178 |
1,073 |
$9K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
50 |
50 |
$9K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
355 |
292 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
148 |
130 |
$9K |
| 80306 |
|
101 |
94 |
$9K |
| 84439 |
|
310 |
303 |
$8K |
| 88141 |
|
642 |
614 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
123 |
123 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
175 |
171 |
$7K |
| 82947 |
|
82 |
68 |
$7K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
164 |
160 |
$6K |
| 86618 |
|
237 |
230 |
$4K |
| 87205 |
|
203 |
197 |
$4K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
138 |
119 |
$3K |
| 83690 |
|
1,037 |
967 |
$3K |
| 0012A |
|
37 |
37 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
99 |
99 |
$2K |
| 87186 |
|
87 |
80 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
50 |
50 |
$1K |
| 94010 |
|
511 |
445 |
$1K |
| 81000 |
|
102 |
83 |
$1K |
| 86803 |
|
50 |
50 |
$1K |
| 0011A |
|
36 |
36 |
$938.86 |
| 83655 |
|
43 |
43 |
$871.10 |
| 85652 |
|
81 |
77 |
$843.64 |
| 99462 |
|
30 |
12 |
$740.92 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
25 |
25 |
$497.60 |
| 87468 |
|
12 |
12 |
$444.65 |
| 87469 |
|
12 |
12 |
$425.32 |
| 87484 |
|
12 |
12 |
$425.32 |
| 99310 |
Prolong nursin fac eval 15m |
16 |
12 |
$335.40 |
| 82570 |
|
38 |
38 |
$325.69 |
| J3490 |
Unclassified drugs |
152 |
114 |
$308.47 |
| 83735 |
|
28 |
25 |
$306.57 |
| 85027 |
|
13 |
13 |
$156.86 |
| 82077 |
|
15 |
14 |
$111.87 |
| 82043 |
|
12 |
12 |
$107.32 |
| 85610 |
|
18 |
14 |
$102.30 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
864 |
764 |
$73.54 |
| 88304 |
|
13 |
13 |
$44.09 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
298 |
261 |
$43.76 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
13 |
12 |
$21.65 |
| 51798 |
|
15 |
15 |
$11.93 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
636 |
579 |
$11.38 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
194 |
190 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
121 |
120 |
$0.00 |
| 90686 |
|
31 |
31 |
$0.00 |
| 91301 |
|
69 |
69 |
$0.00 |